280 related articles for article (PubMed ID: 34789016)
1. VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.
Harris NR; Nielsen NR; Pawlak JB; Aghajanian A; Rangarajan K; Serafin DS; Farber G; Dy DM; Nelson-Maney NP; Xu W; Ratra D; Hurr SH; Qian L; Scallan JP; Caron KM
Circ Res; 2022 Jan; 130(1):5-23. PubMed ID: 34789016
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds.
Hägerling R; Hoppe E; Dierkes C; Stehling M; Makinen T; Butz S; Vestweber D; Kiefer F
EMBO J; 2018 Nov; 37(22):. PubMed ID: 30297530
[TBL] [Abstract][Full Text] [Related]
3. VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance.
Yang Y; Cha B; Motawe ZY; Srinivasan RS; Scallan JP
Cell Rep; 2019 Aug; 28(9):2397-2412.e4. PubMed ID: 31461654
[TBL] [Abstract][Full Text] [Related]
4. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice.
Hoopes SL; Willcockson HH; Caron KM
PLoS One; 2012; 7(9):e45261. PubMed ID: 23028890
[TBL] [Abstract][Full Text] [Related]
6. Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition.
Sung DC; Chen M; Dominguez MH; Mahadevan A; Chen X; Yang J; Gao S; Ren AA; Tang AT; Mericko P; Patton R; Lee M; Jannaway M; Nottebaum A; Vestweber D; Scallan JP; Kahn ML
Nat Cardiovasc Res; 2022 Nov; 1(11):1006-1021. PubMed ID: 36910472
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Connexin 43.
Trincot CE; Xu W; Zhang H; Kulikauskas MR; Caranasos TG; Jensen BC; Sabine A; Petrova TV; Caron KM
Circ Res; 2019 Jan; 124(1):101-113. PubMed ID: 30582443
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
9. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
10. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
11. Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex.
Coon BG; Baeyens N; Han J; Budatha M; Ross TD; Fang JS; Yun S; Thomas JL; Schwartz MA
J Cell Biol; 2015 Mar; 208(7):975-86. PubMed ID: 25800053
[TBL] [Abstract][Full Text] [Related]
12. Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis.
Osinski V; Yellamilli A; Firulyova MM; Zhang MJ; Peck AL; Auger JL; Faragher JL; Marath A; Voeller RK; O'Connell TD; Zaitsev K; Binstadt BA
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):807-821. PubMed ID: 38269589
[TBL] [Abstract][Full Text] [Related]
13. Gαs Relays Sphingosine-1-Phosphate Receptor 1 Signaling to Stabilize Vascular Endothelial-Cadherin at Endothelial Junctions to Control Mouse Embryonic Vascular Integrity.
Shao X; Liu K; Fan Y; Ding Z; Chen M; Zhu M; Weinstein LS; Li H; Li H
J Genet Genomics; 2015 Nov; 42(11):613-624. PubMed ID: 26674379
[TBL] [Abstract][Full Text] [Related]
14. Rab11a Mediates Vascular Endothelial-Cadherin Recycling and Controls Endothelial Barrier Function.
Yan Z; Wang ZG; Segev N; Hu S; Minshall RD; Dull RO; Zhang M; Malik AB; Hu G
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):339-49. PubMed ID: 26663395
[TBL] [Abstract][Full Text] [Related]
15. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
[TBL] [Abstract][Full Text] [Related]
16. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
17. Aberrant lymphatic endothelial progenitors in lymphatic malformation development.
Wu JK; Kitajewski C; Reiley M; Keung CH; Monteagudo J; Andrews JP; Liou P; Thirumoorthi A; Wong A; Kandel JJ; Shawber CJ
PLoS One; 2015; 10(2):e0117352. PubMed ID: 25719418
[TBL] [Abstract][Full Text] [Related]
18. VE-cadherin junction dynamics in initial lymphatic vessels promotes lymph node metastasis.
Sáinz-Jaspeado M; Ring S; Proulx ST; Richards M; Martinsson P; Li X; Claesson-Welsh L; Ulvmar MH; Jin Y
Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38148112
[TBL] [Abstract][Full Text] [Related]
19. Endothelial permeability and VE-cadherin: a wacky comradeship.
Gavard J
Cell Adh Migr; 2013; 7(6):455-61. PubMed ID: 24430214
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade.
Lee SW; Won JY; Lee HY; Lee HJ; Youn SW; Lee JY; Cho CH; Cho HJ; Oh S; Chae IH; Kim HS
Mol Med; 2011; 17(9-10):1095-106. PubMed ID: 21738954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
